News

Article October 14, 2020

Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases

The 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders

Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lab

Gladstone in the News October 2, 2020

Next Wave of Bay Area Neuroscience Companies: What Are They Doing Now?

San Francisco Business Times—Gabaeron, founded by Gladstone President Emeritus Bob Mahley, MD, PhD, and Therini Bio (formerly Medared), founded upon work by Senior Investigator Katarina Akassoglou, PhD, are among Bay Area biotech companies focusing on neurological diseases that collectively raised more than $3 billion from venture capital firms and the public capital markets in 2020.

Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Mahley Lab

Video June 19, 2020

Current and Future Strategies to Treat and Prevent Alzheimer’s Disease

With an estimated 44 million diagnosed with Alzheimer’s disease worldwide, research is moving quickly to better understand the disease.

Gladstone Experts Alzheimer’s Disease Neurological Disease Mahley Lab Mucke Lab

Video April 8, 2020

Preparing a Chalk Talk for a Faculty Position

Demystify the chalk talk and set yourself up for success.

Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs Mahley Lab

Article February 27, 2020

Gladstone Launches New Responsible Conduct of Research Training Program

In 2019, Gladstone launched the Responsible Conduct of Research seminar series as part of its comprehensive training program for postdocs and graduate students.

Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs Institutional News Conklin Lab Mahley Lab

Gladstone in the News February 10, 2020

NIH Awards $4.8M Grant to Project Investigating the Role of ApoE4 Gene Variant in Alzheimer’s

Alzheimer’s News Today—Gladstone scientists recently received $4.8 million from the NIH to study how the protein apoE4 causes neurodegeneration in Alzheimer's disease.

Gladstone Experts Mahley Lab

Article January 29, 2020

NIH Funds Deep-Dive into ApoE4’s Role in Alzheimer’s Disease

With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer’s disease.

Grants News Release Alzheimer’s Disease Neurological Disease Krogan Lab Mahley Lab

Video December 13, 2019

Evolution of Research

Gladstone started as a single institute in 1979 but has since grown to four institutes which use cutting-edge technology to tackle cardiovascular, neurological, and immunological diseases.

History Cardiovascular Disease Data Science and Biotechnology Neurological Disease Virology Greene Lab Mahley Lab Mucke Lab Pollard Lab Srivastava Lab

Article December 12, 2019

Gladstone’s Evolution of Research

Gladstone began as a single entity with a single purpose. But as the scientists followed the science—unencumbered by the red tape of bureaucracy—the purpose, and the focus, grew.

History Institutional News Cardiovascular Disease Data Science and Biotechnology Neurological Disease Virology Finkbeiner Lab Greene Lab Mahley Lab Mucke Lab

Article September 20, 2019

Gladstone’s Alzheimer Research Team: Ahead of the Curve

As clinical trials in Alzheimer's disease have failed, Gladstone investigators are taking innovative approaches to understanding the disease and finding new therapeutic targets.

Research (Publication) Alzheimer’s Disease Dementia Neurological Disease Huang Lab Mahley Lab Mucke Lab Palop Lab Aging Disease Models

Video April 16, 2019

Hail to the Chiefs: Robert Mahley

Learn more about Gladstone's founding President in this video celebrating our 40th anniversary.

History Institutional News Mahley Lab

Article April 12, 2019

Hail to the Chiefs: The Gladstone Presidents

A look at the distinct eras defined by Gladstone’s three presidents

History Institutional News Mahley Lab Srivastava Lab

Article June 26, 2017

Additional Funding to Develop a Drug for Alzheimer’s Disease

E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders

Huang Lab Mahley Lab Alzheimer’s Disease

December 8, 2013

Gladstone’s Robert Mahley Receives Wellcome Trust Funds to Combat Alzheimer’s Disease

SAN FRANCISCO, CA—Alzheimer’s disease is one of the greatest challenges facing modern medicine, but there is new hope in the fight against this deadly disease.

Huang Lab Mahley Lab Neurological Disease Alzheimer’s Disease

December 4, 2012

Gladstone Scientists: “ApoE Is an Ideal Target for Halting Progression of Alzheimer’s Disease”

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes are recommending a shift in efforts to treat Alzheimer’s disease by developing drugs that target the apoE4 protein, which has long been associated with an increased risk for the disease.

Alzheimer’s Disease Huang Lab Mahley Lab